Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.
about
Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of DiabetesGenetic risk prediction in complex diseaseTen-year Diabetes Risk Forecast in the Capital of Jordan: Arab Diabetes Risk Assessment Questionnaire Perspective-A Strobe-Complaint ArticleLow lung function and risk of type 2 diabetes in Japanese men: the Toranomon Hospital Health Management Center Study 9 (TOPICS 9)Development and Validation of a Risk-Score Model for Type 2 Diabetes: A Cohort Study of a Rural Adult Chinese PopulationValidation of the German Diabetes Risk Score within a population-based representative cohort.Lifestyle interventions in preventing new type 2 diabetes in Asian populations.Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort studyA risk assessment model for type 2 diabetes in ChineseEffect of communicating genetic and phenotypic risk for type 2 diabetes in combination with lifestyle advice on objectively measured physical activity: protocol of a randomised controlled trialAdipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.Liver function tests and risk prediction of incident type 2 diabetes: evaluation in two independent cohorts.Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.The value of genetic information for diabetes risk prediction - differences according to sex, age, family history and obesity.Management of NCD in low- and middle-income countries.Understanding perceived risk of type 2 diabetes in healthy middle-aged adults: a cross-sectional study of associations with modelled risk, clinical risk factors, and psychological factorsThe effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy settingIntegrated genomic and BMI analysis for type 2 diabetes risk assessment.Threshold-free measures for assessing the performance of medical screening tests.Independent external validation and comparison of prevalent diabetes risk prediction models in a mixed-ancestry population of South Africa.Evaluation of Major Online Diabetes Risk Calculators and Computerized Predictive Models.A risk score to predict type 2 diabetes mellitus in an elderly Spanish Mediterranean population at high cardiovascular riskChallenges of diabetes prevention in the real world: results and lessons from the Melbourne Diabetes Prevention Study.Microvesicles/exosomes as potential novel biomarkers of metabolic diseasesA Systematic Review of Biomarkers and Risk of Incident Type 2 Diabetes: An Overview of Epidemiological, Prediction and Aetiological Research Literature.Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.Quantifying the risk of type 2 diabetes in East London using the QDScore: a cross-sectional analysis.Predicting Risk of Type 2 Diabetes by Using Data on Easy-to-Measure Risk FactorsEvaluation of the Finnish Diabetes Risk Score to predict type 2 diabetes mellitus in a Colombian population: A longitudinal observational study.Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA StudyAn evaluation of the performance of the NHS Health Check programme in identifying people at high risk of developing type 2 diabetesType 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction.Development and validation of a risk score predicting substantial weight gain over 5 years in middle-aged European men and womenPredictive models for type 2 diabetes onset in middle-aged subjects with the metabolic syndrome.Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.Strategies for preventing type 2 diabetes: an update for clinicians.Preventing type 2 diabetes mellitus: a call for personalized interventionPredicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic reviewImpaired fasting glucose: Pro-diabetic, "atheroprotective" and modified by metabolic syndrome.Development and Validation of a Simple Risk Score for Undiagnosed Type 2 Diabetes in a Resource-Constrained Setting
P2860
Q26795627-94E6B414-A794-48A2-A83C-A031374494F4Q27027720-596FCCAA-0ABA-406B-8892-7BBEDB324342Q28387551-3BB34374-0ACF-4EDF-A3AA-45C96EFC2AEEQ28392788-5F707EB8-CB98-47CB-A6CB-83EBB028C5D9Q28551276-02AC3CA8-651B-4B96-9C0E-06104060ED63Q30317838-E7A26154-BBEF-4F87-BDF2-861F6C347C09Q30380357-C76591D6-0926-4E8C-B266-521C6B72A65AQ33638105-C17F68E9-F7CE-4EC9-A575-2FF7D2602725Q34015539-D5E3C74A-39A2-4EA0-875E-98737FCFB23EQ34307658-7061A318-1ADD-47C7-A8F9-37546617F64DQ34517195-9796C442-425C-4EDB-AD09-FBB1E1B201D7Q34531926-F8B57767-FCE9-4152-94C7-AF7065348AFDQ34600964-826D35BA-55AE-4887-B313-1194A1885EE8Q34735432-0BB1D87A-8D0B-4ABA-994F-68DE8454A4B7Q34987612-5F25EA05-4696-4CE7-9283-A500879E6E2FQ35111808-E8A9DCBA-6780-406F-B6DB-8E6E9948E0EDQ35137431-BAD4BB9E-28E2-473A-8126-38A5EA5346EDQ35184267-B2913962-D761-470C-8CE2-DE98433AAE3EQ35486365-3BA74BB9-5EC8-4EB1-AA78-D254E2014F76Q35619751-0BEE3FB1-5803-452A-9D1B-8583A8763330Q35839066-60D77A7D-75D3-4A59-A698-1D6D2D3A03C8Q35839851-7909C3EE-C585-49B5-9772-CD0E3985FFEBQ36134969-41C5827C-207D-4494-B18D-972EB995885DQ36175435-2BBD8D37-7B2C-4C5F-910A-02701182BA55Q36176050-0ABB76A4-03C5-46EC-997C-E123ECAB5DC6Q36243079-CFA80634-F5BD-47FD-AB10-74C6631E4D9BQ36284246-8388BCB8-9BA4-4374-8071-13A4AA70FFF9Q36302167-3E6C8A16-3484-46C8-9331-48FAA77B2A25Q36356684-F3BB6C83-5EAB-4780-BA2B-8030FB72C14FQ36490447-105B2239-9A95-4B44-8045-D03C5DB20618Q36730033-5F0F2F02-24EC-4FBA-9081-0EE32312539EQ36904049-CDB9BC40-553B-453F-8992-16028E93364AQ37017884-6CE700C6-D7FF-43BD-80C8-DACDF8F1BE2CQ37028898-B8AEAF22-4226-49DB-8BF2-3B41BB4CA7EFQ37057960-F7E0A56C-00C5-4547-BB70-A9E5CCA3ECB7Q37117608-89122DCA-42A4-478B-B5AB-66B06279BDFBQ37197541-287CB681-756A-40D5-BF9D-7F5DA7DAEF9DQ37220830-4C6C6F21-D2EC-4211-B8B3-512D37737C21Q37232688-91444442-0C56-45D2-97BB-7B3300DD1902Q37263148-36E9CA39-3A5D-4E2F-A33D-75A13FD76D06
P2860
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.
@ast
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.
@en
type
label
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.
@ast
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.
@en
prefLabel
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.
@ast
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.
@en
P2860
P50
P921
P356
P1476
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.
@en
P2860
P356
10.1093/EPIREV/MXQ019
P5008
P577
2011-05-27T00:00:00Z